SIRT3, a therapeutic target in DLBCL. SIRT3, a therapeutic target in DLBCL
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA606900
下载链接
链接失效反馈官方服务：
资源简介：
We report that in absence of ATM signaling SIRT3 stimluated pathways are critical for development of DLBCL Overall design: RNA sequencing in DLBCL cell line HLY with wild type ATM (NT-HLY) and HLY cell line expressing shATM lentivirus for genetic inhibition of ATM
创建时间：
2020-02-15
